Article
Influences of CYP2D6*10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis.
Acta pharmacologica Sinica - 1 Nov 2016
Pei Qi, Huang Lu, Huang Jie, Gu Jing-Kai, Kuang Yun, Zuo Xiao-Cong, Ding Jun-Jie, Tan Hong-Yi, Guo Cheng-Xian, Liu Shi-Kun, Yang Guo-Ping
Abstract excerpt
AIM: Iloperidone is an atypical antipsychotic drug that is mainly metabolized by CYP2D6, CYP3A4, and cytosolic enzymes. Previous studies show that extensive and poor metabolizers of CYP2D6 exhibit different plasma concentrations of iloperidone and its metabolites. The aim of this study was to develop a parent-metabolite population pharmacokinetic (PPK) model to quantify the effects of CYP2D6*10 allele on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.